Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • CollPlant Biotechnologies News

    5,86 $ +6,93% +0,38 $
    In : 5,4803 € | 26.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1CY27
    ISIN: IL0004960188
    US-Symbol: CLGN
    Typ: Aktie

    CollPlant Biotechnologies News

    04.04.24 - PR Newswire
    COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire
    04.04.24 - PR Newswire
    COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire
    26.03.24 - PR Newswire
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire
    15.02.24 - PR Newswire
    CollPlant Issues Letter to Shareholders
    CollPlant Issues Letter to Shareholders PR Newswire
    08.01.24 - PR Newswire
    CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
    CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California PR Newswire
    02.01.24 - PR Newswire
    CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
    CollPlant Biotechnologies Begins Preclinical Trial with Commercial-​Size, Regenerative Breast Implants PR Newswire
    29.11.23 - PR Newswire
    CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
    CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023 PR Newswire
    09.11.23 - PR Newswire
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire
    01.11.23 - PR Newswire
    CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
    CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler PR Newswire
    21.09.23 - PR Newswire
    CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative
    CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative PR Newswire
    05.09.23 - PR Newswire
    CollPlant to Present at the H.C. Wainwright Annual Growth Conference
    CollPlant to Present at the H.C. Wainwright Annual Growth Conference PR Newswire
    24.08.23 - PR Newswire
    CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
    CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million PR Newswire
    09.08.23 - PR Newswire
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire
    26.06.23 - PR Newswire
    Thinking about buying stock in Trxade Health, Eco Wave Power, Collplant Biotechnologies, C3.Ai, or PetVivo?
    Thinking about buying stock in Trxade Health, Eco Wave Power, Collplant Biotechnologies, C3.Ai, or PetVivo? PR Newswire
    26.06.23 - PR Newswire
    CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement
    CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement PR Newswire
    24.05.23 - PR Newswire
    CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update
    CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update PR Newswire
    02.05.23 - PR Newswire
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire
    29.03.23 - PR Newswire
    Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update
    Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update PR Newswire
    14.03.23 - PR Newswire
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire
    24.01.23 - PR Newswire
    CollPlant Issues Letter to Shareholders
    CollPlant Issues Letter to Shareholders PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »